Alcon Inc. (ALC)

USD 98.3

(2.21%)

Total Liabilities Summary of Alcon Inc.

Alcon Inc.'s latest annual total liabilities in 2023 was 8.98 Billion USD , down -5.72% from previous year.
Alcon Inc.'s latest quarterly total liabilities in 2024 Q2 was 8.77 Billion USD , up 0.45% from previous quarter.
Alcon Inc. reported annual total liabilities of 9.53 Billion USD in 2022, up 9.02% from previous year.
Alcon Inc. reported annual total liabilities of 8.74 Billion USD in 2021, down -0.4% from previous year.
Alcon Inc. reported quarterly total liabilities of 8.73 Billion USD for 2024 Q1, down -2.77% from previous quarter.
Alcon Inc. reported quarterly total liabilities of 9.26 Billion USD for 2023 Q2, down -1.55% from previous quarter.

Annual Total Liabilities Chart of Alcon Inc. (2023 - 2015)

Historical Annual Total Liabilities of Alcon Inc. (2023 - 2015)

Year	Total Liabilities	Total Liabilities Growth
2023	8.98 Billion USD	-5.72%
2022	9.53 Billion USD	9.02%
2021	8.74 Billion USD	-0.4%
2020	8.77 Billion USD	5.1%
2019	8.35 Billion USD	88.83%
2018	4.42 Billion USD	1.47%
2017	4.35 Billion USD	-7.8%
2016	4.72 Billion USD	3.57%
2015	4.56 Billion USD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	8.77 Billion USD	0.45%
2024 Q1	8.73 Billion USD	-2.77%
2023 Q2	9.26 Billion USD	-1.55%
2023 Q1	9.4 Billion USD	-1.31%
2023 Q3	9.2 Billion USD	-0.55%
2023 FY	8.98 Billion USD	-5.72%
2023 Q4	8.98 Billion USD	-2.42%
2022 FY	9.53 Billion USD	9.02%
2022 Q4	9.53 Billion USD	16.97%
2022 Q2	8.18 Billion USD	-1.42%
2022 Q1	8.3 Billion USD	-5.02%
2022 Q3	8.14 Billion USD	-0.45%
2021 FY	8.74 Billion USD	-0.4%
2021 Q4	8.74 Billion USD	0.39%
2021 Q1	8.45 Billion USD	-3.68%
2021 Q2	8.68 Billion USD	2.73%
2021 Q3	8.7 Billion USD	0.26%
2020 Q2	8.7 Billion USD	8.47%
2020 FY	8.77 Billion USD	5.1%
2020 Q4	8.77 Billion USD	0.23%
2020 Q3	8.75 Billion USD	0.57%
2020 Q1	8.02 Billion USD	-3.88%
2019 Q1	- USD	-100.0%
2019 FY	8.35 Billion USD	88.83%
2019 Q4	8.35 Billion USD	1.26%
2019 Q3	8.24 Billion USD	-0.89%
2019 Q2	8.32 Billion USD	0.0%
2018 Q3	4.2 Billion USD	0.0%
2018 FY	4.42 Billion USD	1.47%
2018 Q1	- USD	-100.0%
2018 Q4	4.42 Billion USD	5.28%
2017 Q4	4.35 Billion USD	0.0%
2017 FY	4.35 Billion USD	-7.8%
2016 FY	4.72 Billion USD	3.57%
2015 FY	4.56 Billion USD	0.0%

Peer Total Liabilities Comparison of Alcon Inc.

Name	Total Liabilities	Total Liabilities Difference
AptarGroup, Inc.	2.13 Billion USD	-321.806%
Baxter International Inc.	19.8 Billion USD	54.63%
Becton, Dickinson and Company	26.98 Billion USD	66.695%
Bausch + Lomb Corporation	6.52 Billion USD	-37.794%
Haemonetics Corporation	1.23 Billion USD	-627.317%
Envista Holdings Corp	2.43 Billion USD	-269.651%
ResMed Inc.	2 Billion USD	-347.479%
Teleflex Incorporated	3.09 Billion USD	-190.693%
Warby Parker Inc.	278.52 Million USD	-3126.624%
West Pharmaceutical Services, Inc.	948.5 Million USD	-847.491%